These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 22122395

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
    Ksouda K, Affes H, Atheymen R, Ezzeddine M, Zeghal K, Hammami S.
    Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML, Diallo S, Mbengue M, Moreira-Diop T.
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis.
    Osuga T, Ikura Y, Kadota C, Hirano S, Iwai Y, Hayakumo T.
    Int J Clin Exp Pathol; 2015; 8(2):1961-6. PubMed ID: 25973089
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Amital H, Arnson Y, Chodick G, Shalev V.
    Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
    [Abstract] [Full Text] [Related]

  • 11. Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B.
    Tang KT, Hung WT, Chen YH, Lin CH, Chen DY.
    Sci Rep; 2016 Mar 01; 6():22387. PubMed ID: 26928373
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Liver toxicity is rare in rheumatoid arthritis patients using combination therapy with leflunomide and methotrexate.
    Alves JA, Fialho SC, Morato EF, Castro GR, Zimmermann AF, Ribeiro GG, Neves FS, Pereira IA.
    Rev Bras Reumatol; 2011 Mar 01; 51(2):141-4. PubMed ID: 21584420
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adalimumab-induced autoimmune hepatitis.
    Adar T, Mizrahi M, Pappo O, Scheiman-Elazary A, Shibolet O.
    J Clin Gastroenterol; 2010 Jan 01; 44(1):e20-2. PubMed ID: 19593165
    [Abstract] [Full Text] [Related]

  • 18. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms.
    Ezhilarasan D.
    Toxicology; 2021 Jun 30; 458():152840. PubMed ID: 34175381
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: A randomized controlled clinical trial.
    Huang RY, Pan HD, Wu JQ, Zhou H, Li ZG, Qiu P, Zhou YY, Chen XM, Xie ZX, Xiao Y, Huang QC, Liu L.
    Phytomedicine; 2019 Apr 30; 57():403-410. PubMed ID: 30851515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.